Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Citrate and Heparin Lock vs Heparin Alone in Chronic Hemodialysis
TCTR20251021002Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Oct 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of trisodium citrate, heparin in end-stage kidney disease (ESKD), sponsored by Ramathibodi Hospital. Started Oct 2024; status: completed.
02
Drugs
trisodium citrateheparin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20251021002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251021002.